GlassScriptPhysician profile
Arun Ramesh Kumar
NPI 1831694843
$9,678.37
in general payments reported to CMS, 2019-2025
8 companies · $630 in 2025
The $630 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $20.75 · 2023: $4,605 · 2024: $4,422 · 2025: $630.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $3,500 · Grant: $3,500 · Food and Beverage: $2,424 · Travel and Lodging: $234.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $3,500.00 |
| Grant | $3,500.00 |
| Food and Beverage | $2,423.52 |
| Travel and Lodging | $234.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $7,093.43 | 2023-2024 | Journey II, Redapt, Legion |
| Stryker Corporation | $1,689.32 | 2023-2025 | Mako, Triathlon |
| Zimmer Biomet Holdings, INC. | $709.99 | 2023-2025 | Persona, Arcos, Avenir |
| Depuy Synthes Sales INC. | $62.67 | 2023 | Na, Fibulink |
| Medacta USA, INC. | $59.00 | 2023 | Gmk Sphere |
| Astrazeneca Pharmaceuticals LP | $22.84 | 2023 | Lokelma |
| Daiichi Sankyo INC. | $20.75 | 2021 | |
| Janssen Pharmaceuticals, INC | $20.37 | 2024 | Xarelto |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arun Kumar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.